Zinnet Şevval Aksoyalp

Akademik Profiller

1. 1
   A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2024.Naunyn-Schmiedeberg's archives of pharmacology
   2025
2. 2
   Trimethylamine N-oxide as a potential prognostic biomarker for mortality in patients with COVID-19 diseaseAdvances in Medical Sciences
   2025
3. 3
   Comparative Post‐Marketing Surveillance of Memantine and Cholinesterase Inhibitors: Cardiovascular Adverse Events With a Focus on Sex Differences Using the FDA Adverse Event Reporting System DatabaseInternational Journal of Geriatric Psychiatry
   2024
4. 4
   Pharmacological Innovations in Space: Challenges and Future PerspectivesPharmaceutical Research
   2024
5. 5
   Type 1 Diabetes Mellitus and Herbal MedicinesHerbal Medicine for Autoimmune Diseases
   2024
6. 6
   Licorice: Evaluation of Phytochemical Neuropharmacological Profile and Drug Interactions with a Focus on Gut MicrobiotaScience of Spices and Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical Studies: Volume 6
   2024
7. 7
   COMPARATIVE EVALUATION OF ARTIFICIAL INTELLIGENCE AND DRUG INTERACTION TOOLS: A PERSPECTIVE WITH THE EXAMPLE OF CLOPIDOGRELAnkara Universitesi Eczacilik Fakultesi Dergisi
   2024
8. 8
   Plant phenolic acids modulating the renin-angiotensin system in the management of cardiovascular diseasesStudies in Natural Products Chemistry
   2024
9. 9
   Urinary Tract Infections and Fungal Infections Associated with SGLT-2 Inhibitors and Metformin Combination: A real-world study from 2013 to 2023 based on FAERS databaseJournal of Clinical Practice and Research
   2024
10. 10
    A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023.Naunyn-Schmiedeberg's archives of pharmacology
    2024

Yayın listesi ORCID kaydından alındı.